Everest Organics Ltd.

View in App
123.05 -1.55 ▼-1.2%

18 April 2024, 04:01:00 PM
Volume: 2,259

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.everestorganicsltd.com
Market Cap 100.00 Cr.
Enterprise Value(EV) 156.12 Cr. 2023-12
Financial Indicators
Earnings per share (EPS) 0.24 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 518.13 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 57.47 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.18 Calculated using Price: 125.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.80 Cr. 8,000,000 Shares
FaceValue 10
About Everest Organics Ltd.
The company's facilities comply to GMP standards and is certified by the Drug Control Authority of the Government of Andhra Pradesh, India. It supply products to major multinational companies abroad, prominent well established formulation companies in India, Europe, USA, Far East and the Middle East, and also to Latin / Central / South American Countries. The company also provides adequate technical & documentary support for their products and its products comply to various pharmacopial standards like BP, USP, EP and IP Standards as desired by the customer.

Everest Organics Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Everest Organics Ltd. Performance

View details >>
1 Day
-1.24%
1 Week
-4.24%
1 Month
+2.76%
3 Month
-16.97%
6 Month
-3.11%
1 Year
+19.84%
2 Year
-36.75%
5 Year
-42.08%
10 Year

Everest Organics Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 33.19 3.06 12.25 9.86 33.63 36.22 33.96 2.45 -0.39
Return on Capital Employed (%) 15.84 8.9 13.55 13.8 35.3 35.22 33.76 6.25 3.72
Return on Assets (%) 2.5 0.25 1.67 1.9 7.45 9.58 10.73 0.73 -0.1

Everest Organics Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12* Rs. Cr.
Shh. Funds 6 6 16 19 26 34 47 47 46 46
Non Curr. Liab. 11 14 7 8 10 12 11 19 18 21
Curr. Liab. 50 56 63 67 71 74 77 113 138 158
Minority Int.
Equity & Liab. 67 76 86 94 107 120 135 178 202 225
Non Curr. Assets 25 29 37 36 40 41 46 60 69 77
Curr. Assets 42 47 49 58 67 79 89 118 132 148
Misc. Exp. not W/O
Total Assets 67 76 86 94 107 120 135 178 202 225

Everest Organics Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 106 99 107 112 156 167 182 200 183 195
Other Income 1 1 1 1 1 1 1 2 7 1
Total Income 107 100 108 113 156 169 183 202 190 197
Total Expenditure -98 -94 -101 -105 -138 -148 -159 -194 -182 -185
PBIDT 8 6 7 8 18 21 24 9 8 12
Interest -3 -3 -3 -3 -3 -3 -3 -3 -3 -5
Depreciation -3 -3 -2 -3 -3 -3 -3 -4 -4 -5
Taxation 0 0 0 -1 -5 -3 -4 -1 0 -1
Exceptional Items -1 -1
PAT 2 0 1 2 8 11 14 1 0 0
Adjusted EPS 2 1 2 2 9 14 17 1 0 0

Everest Organics Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 4 7 10 5 9 10 14 14 18
Cash Fr. Inv. -3 -3 -7 -8 -4 -5 -6 -12 -17 -16
Cash Fr. Finan. 2 -2 0 -2 0 -3 -3 -2 2 -3
Net Change 0 0 0 0 1 1 0 0 -1 0
Cash & Cash Eqvt 1 1 1 1 1 2 2 2 1 1

Everest Organics Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 74.15 74.15 74.15 74.15 74.15 74.15 74.15 74.15 74.15
Public 25.85 25.85 25.85 25.85 25.85 25.85 25.85 25.85 25.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Everest Organics Ltd. Announcements

View details >>
Wed, 10 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please see annexed enclosure.
Fri, 29 Mar 2024
Closure of Trading Window
Please see annexed enclosure.
Sat, 10 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please see annexed enclosure.

Everest Organics Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
Higher Trade Quantity Higher Trade Quantity
Opening at Low Opening at Low
High Decrease in 3 Months High Decrease in 3 Months
MFI Trending Up MFI Trending Up
Closing Near 200 SMA Closing Near 200 SMA

Everest Organics Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,523.80 -0.9%
Cipla Ltd. 108,808.58 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,959.10 -1.5%
Divi's Laboratories Ltd. 98,683.96 3,717.35 -1.3%
Mankind Pharma Ltd. 96,037.07 2,397.40 +5.0%
Zydus Lifesciences Ltd. 94,213.69 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,107.00 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 29.34 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,107.00 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 4.20 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,107.00 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,107.00 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,107.00 -3.6%

Everest Organics Ltd. FAQ's

What is Everest Organics share price?
Can I buy Everest Organics shares now?
What is the Market Cap of Everest Organics?
What are the key metrics to analyse Everest Organics?
What is the 52 Week High and Low of Everest Organics?
What is the trend of Everest Organics share price?